top of page
Products

ALVIT LEVERAGES ITS EXPERTISE IN CULTIVATION, EXTRACTION, PHARMACOLOGY, AND FORMULATION TO RESEARCH AND DEVELOP PHARMA GRADE CANNABIS PRODUCTS FOR DELIVERY IN ADVANCED PROPRIETARY DRUG DELIVERY TECHNOLOGIES.

Alvit's product development cycle

01

AGRO

 

Cultivation

​

Controlled Environment (GAP)

process-02.png

02

API's

​

Development of unique extraction methodologies

​

Unique Compositions

process-03.png

03

PHARMACOLOGICAL PROFILE

 

In Viva POC

​

​

Pharma profile-01.png

04

FORMULAION

​

Matching The Right Formulation With The Pharmacology & Indication

process-05.png

Alvit develops specific compositions incorporating novel delivery methods for each target indication.

!

ALVIT NOVEL FORMULATIONS & DELIVERY SYSTEMS

SELF NANO-EMULSIFYING SUBLINGUAL TABLETS

Alvit’s nano self emulsifying sublingual tablets are ideal for quickly delivering precise doses of cannabinoids into the body. Onset time is only 5-10 minutes providing patients near immediate relief that lasts for about 4 hours. The product has recently completed a clinical trial in Israel.

EXTENDED RELEASE TABLETS

Alvit’s extended release tablets were designed for patients that require continuous relief from their symptoms with minimal side effects. Onset time is approximately 45 minutes and the tablet will provide continuous relief for 12-14 hours. The product has recently been approved for clinical trial in Israel.

COLONIC DELIVERY TABLETS

Alvit’s colonic delivery tablets were designed for patients that require relief from intestinal diseases and syndromes that require delivery of cannabis to the activity site. Onset time is approximately 4-5 hours and the tablet will provide continuous relief for 12-14 hours. The product has recently been approved for clinical trial in Israel.

SELF NANO-EMULSIFYING CANNABIS SPRAY

Similar to the sublingual tablets, Alvit’s self nano-emulsifying cannabis spray is  ideal for quickly delivering precise doses of cannabinoids into the body. Onset time is only 5-10 minutes providing patients near immediate relief that lasts for about 4 hours. The product has recently been approved for clinical trial in Israel.

SUPPOSITORIES

Alvit’s fast acting suppositories are appropriate for all ages and are especially useful in the pediatric and geriatric markets where patients sometimes have difficulty swallowing tablets and pills, and for patients suffering from colorectal diseases. 

SELF NANO-EMULSIFYING ENTERICOATED DELAYED RELEASE TABLETS

Alvit’s delayed release tablets were designed to release the active ingredient after passing the stomach. Onset time is 1.5-2 hours and provides continuous relief for 12-14 hours.

!
bottom of page